No significant strengths identified
| Name | Market Cap | Current Price | P/E Ratio | Revenue Growth 1Y | Net Margin | ROE | FCF Yield | Debt/Equity |
|---|---|---|---|---|---|---|---|---|
| RYANRyan Specialty Holdings, Inc. | 6.5B | 50.48 | 71.10 | 21.09% | 2.33% | 5.62% | 7.2% | 3.15 |
| Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|
| Revenue | 765.11M | 1.02B | 1.43B | 1.73B | 2.08B | 2.52B |
| Revenue Growth % | - | 0.33% | 0.41% | 0.2% | 0.2% | 0.21% |
| Medical Costs & Claims | 0 | 0 | 0 | 0 | 0 | 0 |
| Medical Cost Ratio % | - | - | - | - | - | - |
| Gross Profit | 765.11M | 1.02B | 1.43B | 1.73B | 2.08B | 2.52B |
| Gross Margin % | - | - | - | - | - | - |
| Gross Profit Growth % | - | 0.33% | 0.41% | 0.2% | 0.2% | 0.21% |
| Operating Expenses | 697.13M | 938.81M | 1.37B | 1.55B | 1.84B | 2.24B |
| OpEx / Revenue % | - | - | - | - | - | - |
| Depreciation & Amortization | 53.1M | 67.5M | 112.68M | 109.29M | 115.84M | 167.63M |
| Combined Ratio % | - | - | - | - | - | - |
| Operating Income | 67.98M | 79.47M | 61.56M | 179.19M | 237.93M | 272.55M |
| Operating Margin % | - | - | - | - | - | - |
| Operating Income Growth % | - | 0.17% | -0.23% | 1.91% | 0.33% | 0.15% |
| EBITDA | 121.08M | 146.97M | 174.25M | 288.48M | 353.76M | 440.18M |
| EBITDA Margin % | - | - | - | - | - | - |
| Interest Expense | 35.55M | 47.24M | 79.35M | 104.83M | 119.51M | 158.45M |
| Non-Operating Income | -35.55M | -47.24M | -79.35M | -104.83M | -119.51M | -158.45M |
| Pretax Income | 67.98M | 79.47M | 61.56M | 179.19M | 237.93M | 272.55M |
| Pretax Margin % | - | - | - | - | - | - |
| Income Tax | 4.93M | 8.95M | 4.93M | 15.94M | 43.45M | 42.64M |
| Effective Tax Rate % | - | - | - | - | - | - |
| Net Income | 64.17M | 68.1M | 65.87M | 61.05M | 61.04M | 94.67M |
| Net Margin % | - | - | - | - | - | - |
| Net Income Growth % | - | 0.06% | -0.03% | -0.07% | -0% | 0.55% |
| EPS (Diluted) | 0.60 | 0.64 | 0.62 | 0.61 | 0.52 | 0.71 |
| EPS Growth % | - | 0.07% | -0.03% | -0.02% | -0.15% | 0.37% |
| EPS (Basic) | 0.60 | 0.64 | 0.62 | 1.50 | 0.57 | 0.78 |
| Diluted Shares Outstanding | 106.49M | 106.49M | 105.73M | 265.75M | 125.75M | 132.89M |
| Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|
| Total Assets | 2.19B | 4.53B | 5.46B | 6.38B | 7.25B | 9.65B |
| Asset Growth % | - | 1.07% | 0.21% | 0.17% | 0.14% | 0.33% |
| Total Investment Assets | 22.52M | 47.22M | 45.42M | 84.37M | 75.77M | 84.81M |
| Long-Term Investments | 22.52M | 47.22M | 45.42M | 84.37M | 75.77M | 70.88M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Current Assets | 1.42B | 2.49B | 3.01B | 3.89B | 4.34B | 0 |
| Cash & Equivalents | 52.02M | 312.65M | 386.96M | 992.72M | 838.79M | 540.2M |
| Receivables | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K |
| Other Current Assets | 1.22B | 1.99B | 2.39B | 2.64B | 3.17B | -4.79B |
| Goodwill & Intangibles | 693.75M | 1.83B | 1.88B | 1.8B | 2.26B | 4.12B |
| Goodwill | 528.51M | 1.22B | 1.31B | 1.31B | 1.65B | 2.65B |
| Intangible Assets | 165.24M | 604.76M | 573.93M | 486.44M | 610.67M | 1.48B |
| PP&E (Net) | 11.56M | 111.36M | 100.16M | 175.14M | 170.13M | 183.47M |
| Other Assets | 41.26M | 48.49M | 418.92M | 428.73M | 408.56M | -4.38B |
| Total Liabilities | 2.13B | 4.21B | 4.86B | 5.57B | 6.27B | 8.55B |
| Total Debt | 669.27M | 1.69B | 1.68B | 2.16B | 2.16B | 3.46B |
| Net Debt | 617.26M | 1.38B | 1.3B | 1.16B | 1.32B | 2.92B |
| Long-Term Debt | 660.03M | 1.57B | 1.57B | 1.95B | 1.94B | 3.23B |
| Short-Term Debt | 9.25M | 19.01M | 23.43M | 30.59M | 35.37M | 51.73M |
| Total Current Liabilities | 1.43B | 2.47B | 2.92B | 3.13B | 3.74B | 0 |
| Accounts Payable | 45.93M | 70.15M | 83.9M | 87.02M | 127.39M | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 1.22B | 2.01B | 2.41B | 2.64B | 3.14B | -73.84M |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 1000K |
| Other Liabilities | 39.23M | 86.41M | 304.78M | 327.72M | 424.97M | -3.43B |
| Total Equity | 63.15M | 320.23M | 594.78M | 817.81M | 979.64M | 1.1B |
| Equity Growth % | - | 4.07% | 0.86% | 0.37% | 0.2% | 0.12% |
| Shareholders Equity | 64.26M | 318.93M | 343.77M | 478.4M | 559.75M | 627.66M |
| Minority Interest | -1.11M | 1.3M | 251M | 339.41M | 419.89M | 470.62M |
| Retained Earnings | -173.75M | 0 | -7.06M | 53.99M | 114.42M | 122.94M |
| Common Stock | 97.5M | 0 | 259K | 259K | 261K | 261K |
| Accumulated OCI | 864K | 69.79M | 1.71M | 6.03M | 3.08M | -1.8M |
| Return on Equity (ROE) | 1.02% | 0.36% | 0.14% | 0.09% | 0.07% | 0.09% |
| Return on Assets (ROA) | 0.03% | 0.02% | 0.01% | 0.01% | 0.01% | 0.01% |
| Equity / Assets | - | - | - | - | - | - |
| Debt / Equity | 10.60x | 5.27x | 2.83x | 2.64x | 2.20x | 3.15x |
| Book Value per Share | 0.59 | 3.01 | 5.63 | 3.08 | 7.79 | 8.26 |
| Tangible BV per Share | - | - | - | - | - | - |
| Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|
| Cash from Operations | 149.51M | 135.39M | 273.49M | 335.51M | 477.2M | 514.87M |
| Operating CF Growth % | - | -0.09% | 1.02% | 0.23% | 0.42% | 0.08% |
| Operating CF / Revenue % | - | - | - | - | - | - |
| Net Income | 63.06M | 70.51M | 56.63M | 163.26M | 194.48M | 229.91M |
| Depreciation & Amortization | 53.1M | 67.5M | 112.68M | 109.29M | 115.84M | 167.63M |
| Stock-Based Compensation | 8.15M | 10.8M | 67.53M | 77.48M | 69.74M | 79M |
| Deferred Taxes | -800K | 203K | -1.15M | 14.54M | 36.66M | 24.22M |
| Other Non-Cash Items | 5.56M | 27.89M | 67.23M | 45.94M | 22.59M | 43.49M |
| Working Capital Changes | 20.44M | -41.51M | -29.44M | -74.99M | 37.9M | -29.38M |
| Cash from Investing | -148M | -768.51M | -457.94M | -22.42M | -476.23M | -1.76B |
| Capital Expenditures | -7.99M | -12.5M | -9.78M | -15.04M | -29.78M | -47M |
| Acquisitions | -144.4M | -741.46M | -108.88M | 0 | -446.68M | -1.71B |
| Purchase of Investments | 0 | 0 | 0 | 0 | 0 | 0 |
| Sale/Maturity of Investments | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Investing | 4.39M | -14.55M | -339.27M | -7.38M | 228K | 0 |
| Cash from Financing | 62.27M | 1.13B | 429.28M | 314.76M | -12.61M | 1.17B |
| Dividends Paid | -72.29M | -50.12M | 0 | -39.88M | 0 | -80.24M |
| Share Repurchases | -3.17M | -52.56M | -967.85M | -7.17M | 0 | 0 |
| Stock Issued | 0 | 0 | 1.45B | 0 | 0 | 0 |
| Debt Issuance (Net) | 1000K | 1000K | -1000K | 1000K | -1000K | 1000K |
| Other Financing | 58.91M | 176.2M | 45.03M | -15.66M | 3.89M | -37.55M |
| Net Change in Cash | 64.05M | 493.54M | 243.96M | 627.72M | -11.05M | -75.53M |
| Exchange Rate Effect | 265K | 1000K | -883K | -126K | 584K | -1000K |
| Cash at Beginning | 338.11M | 402.16M | 895.7M | 1.14B | 1.77B | 1.76B |
| Cash at End | 402.16M | 895.7M | 1.14B | 1.77B | 1.76B | 1.68B |
| Free Cash Flow | 141.52M | 122.89M | 263.71M | 320.47M | 447.43M | 467.87M |
| FCF Growth % | - | -0.13% | 1.15% | 0.22% | 0.4% | 0.05% |
| FCF Margin % | - | - | - | - | - | - |
| FCF per Share | 1.33 | 1.15 | 2.49 | 1.21 | 3.56 | 3.52 |
| Metric | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Combined Ratio | 91.11% | 92.2% | 95.7% | 89.61% | 88.55% | 89.17% |
| Medical Cost Ratio | 0% | 0% | 0% | 0% | 0% | 0% |
| Return on Equity (ROE) | 101.6% | 35.53% | 14.4% | 8.64% | 6.79% | 9.11% |
| Return on Assets (ROA) | 2.93% | 2.03% | 1.32% | 1.03% | 0.9% | 1.12% |
| Equity / Assets | 2.88% | 7.07% | 10.9% | 12.81% | 13.52% | 11.38% |
| Book Value / Share | 0.59 | 3.01 | 5.63 | 3.08 | 7.79 | 8.26 |
| Debt / Equity | 10.60x | 5.27x | 2.83x | 2.64x | 2.20x | 3.15x |
| Revenue Growth | - | 33.09% | 40.71% | 20.41% | 20.42% | 21.09% |
| 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|
| Wholesale Brokerage | 931.98M | 1.13B | 1.32B | 1.49B |
| Wholesale Brokerage Growth | - | 21.17% | 16.81% | 12.89% |
| Underwriting Management | 290.58M | 351.57M | 431.58M | 646.22M |
| Underwriting Management Growth | - | 20.99% | 22.76% | 49.73% |
| Binding Authorities | 209.62M | 231.05M | 275.96M | 320.38M |
| Binding Authorities Growth | - | 10.22% | 19.44% | 16.10% |
| 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|
| UNITED STATES | - | - | - | 2.39B |
| UNITED STATES Growth | - | - | - | - |
| Non-US | - | - | - | 123.73M |
| Non-US Growth | - | - | - | - |
Ryan Specialty Holdings, Inc. (RYAN) has a price-to-earnings (P/E) ratio of 71.1x. This suggests investors expect higher future growth.
Ryan Specialty Holdings, Inc. (RYAN) grew revenue by 21.1% over the past year. This is strong growth.
Yes, Ryan Specialty Holdings, Inc. (RYAN) is profitable, generating $69.2M in net income for fiscal year 2024 (3.8% net margin).
Yes, Ryan Specialty Holdings, Inc. (RYAN) pays a dividend with a yield of 1.20%. This makes it attractive for income-focused investors.
Ryan Specialty Holdings, Inc. (RYAN) has a return on equity (ROE) of 9.1%. This is below average, suggesting room for improvement.
Ryan Specialty Holdings, Inc. (RYAN) has a combined ratio of 0.0%. A ratio below 100% indicates underwriting profitability.